What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings
Open Access
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Cytotherapy
- Vol. 22 (7) , 388-397
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Innovation in the pharmaceutical industry: New estimates of R&D costsJournal of Health Economics, 2016
- Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedureJournal of Translational Medicine, 2016
- Are there Specific Translational Challenges in Regenerative Medicine? Lessons from Other FieldsRegenerative Medicine, 2015
- Time-Driven Activity-Based Costing Trumps Traditional Cost Accounting for RadiologistsAmerican Journal of Roentgenology, 2015
- History of gene therapyGene, 2013
- Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costsCytotherapy, 2013
- Vector Production in an Academic Environment: A Tool to Assess Production CostsHuman Gene Therapy Methods, 2013
- A process‐oriented analysis of facility management services in hospitals as a basis for strategic planningJournal of Facilities Management, 2009
- Comparing methodologies for the cost estimation of hospital servicesThe European Journal of Health Economics, 2008
- Current status of JACIE accreditation in Europe: a special report from the Joint Accreditation Committee of the ISCT and the EBMT (JACIE)Bone Marrow Transplantation, 2007